ENIGMA Bipolar Initiative: A Global Study of Imaging Genomics & Clinical Outcomes
ENIGMA 双极倡议:影像基因组学的全球研究
基本信息
- 批准号:10598611
- 负责人:
- 金额:$ 58.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAgeAge of OnsetAntidepressive AgentsAttentionAustraliaBayesian MethodBehavioralBipolar DisorderBipolar IBrainBrain imagingBrain regionBrazilCanadaCapitalCategoriesChronicClinicalCollectionComplexCorpus CallosumCountryDataData CollectionData ElementDiagnosisDiagnosticDiffuseDiffusionDiffusion Magnetic Resonance ImagingDiseaseDisease ProgressionDoseEmotionsEthnic OriginEvaluationFamilyFirst Degree RelativeFranceFunctional Magnetic Resonance ImagingFunctional disorderGeneral PopulationGeneticGenetic Predisposition to DiseaseGenetic RiskGenomicsGermanyImageImpairmentIndividualInfrastructureInternationalInvestigationJapanLettersLifeLife ExpectancyLinkLongevityMajor Depressive DisorderManicMapsMeasuresMental DepressionModelingMonitorMoodsNetherlandsNeurobiologyNeurosciencesNew YorkNorwayObesityOutcomePatientsPatternPersonal SatisfactionPharmaceutical PreparationsPhenotypePower SourcesPredictive ValuePrefrontal CortexProductivityPrognosisProtocols documentationRecoveryReportingReproducibilityResearchResearch Domain CriteriaResourcesRestRewardsRiskSamplingScanningSeveritiesSiteSleep disturbancesSouth AfricaStandardizationStructureSuicide attemptSusceptibility GeneSymptomsSystemTalentsTestingTherapeuticThickTreatment outcomeWomanWorkassociated symptombiomarker validationbiotypesclinical imagingcohortcomorbiditycomparison controlcostcost effectivecrowdsourcingdata harmonizationdata-driven modeldemographicsdepressive symptomsdesigndisorder subtypeemotion dysregulationfollow-upfunctional disabilityfunctional outcomesgenetic variantgenomic biomarkergenomic dataimaging biomarkerimaging detectionimaging studyimprovedinnovationmenmultimodalityneuroimagingoutcome predictionpatient subsetspolygenic risk scorepsychosocialresiliencesocial relationshipssuicide ratetooltreatment effecttreatment responsewhite matterworking group
项目摘要
ABSTRACT
Bipolar disorder (BD) is a devastating and poorly understood illness. Its burden exceeds $202 billion a year in
direct treatment, societal and family costs. With no known cure and limited therapeutic options, 50% of patients
attempt suicide at least once; up to 30% of patients do not respond to first-line treatment - even with the latest
medications and psychosocial therapy - yet bipolar disorder has only received a small fraction of the amount of
research attention that goes into serious non-psychiatric illness. Differentiating BD from major depression is
crucial for understanding BD pathophysiology. Advances in imaging are beginning to offer the first detailed,
reproducible, and reliable data on brain changes in BD and how they progress, but the lack of global initiatives
in bipolar disorder has stalled research. The high cost of data collection - few studies scan more than a hundred
patients - has led to underpowered studies whose findings often fail to replicate, cannot adequately model
confounds, and often lack power to identify factors that modulate disease progression or recovery. Our ENIGMA
Bipolar Initiative offers a new, cost-effective, innovative global approach - a new source of power to unblock this
logjam by merging resources, capital infrastructure and talents of leading BD centers including data from
48 cohorts across the world. ENIGMA’s Global Alliance for Worldwide Imaging Genomics in Bipolar
Disorder - builds on our thriving ENIGMA Consortium. ENIGMA’s approach merges data from tens of thousands
of individuals and “gives us a power we have not had”, and is “breaking the logjam in neuroscience” (New York
Times). The Lancet hailed ENIGMA as “Crowdsourcing meets Neuroscience”. In designing the ENIGMA-Bipolar
initiative, we identified the most productive activities in the ENIGMA Bipolar working group, and organized them
into 3 themes - imaging, genomics, and cross-disorder comparisons. This global initiative tackles key
questions in BD: how does the illness affect the brain? What imaging and genomic biomarkers assist diagnosis,
monitor treatment, and predict outcomes? How do BD genetic susceptibility loci affect the brain? With global
data and expert teams from 15 countries (see Support Letters), we tackle imaging, genomic, and predictive
questions about BD with unprecedented power. Across Brazil, Japan, the US, Canada, Norway, The
Netherlands, Germany, France, Australia, and South Africa - what brain differences do we reproducibly
detect in BD (with structural/diffusion MRI, connectomics and resting state fMRI)? How do they vary across life,
with illness duration, by demographics, in women versus men, by age of onset, subtype and treatment? Using
ENIGMA’s harmonized protocols, we will analyze the largest collection of multisite neuroimaging data in BD -
diverse in age, ethnicity, treatment response - to track disease worldwide. In a new Cross-Disorder partnership
of ENIGMA-BD and MDD, we use ENIGMA’s data-driven models to detect imaging and genomic biomarkers to
distinguish the 2 disorders and identify subtypes. After harmonizing data elements across disorders, we will
create a ranked list of actionable factors that affect prognosis in BD.
摘要
双相情感障碍(BD)是一种毁灭性的和知之甚少的疾病。它的负担每年超过2020亿美元,
直接治疗、社会和家庭成本。由于没有已知的治愈方法和有限的治疗选择,50%的患者
至少有一次试图自杀;高达30%的患者对一线治疗没有反应-即使是最新的治疗。
药物和心理治疗-然而双相情感障碍只收到了一小部分的金额,
对严重非精神疾病的研究关注。BD与重度抑郁症的区别在于
对理解BD病理生理学至关重要。成像技术的进步开始提供第一个详细的,
关于BD大脑变化及其进展的可重复和可靠的数据,但缺乏全球倡议
双相情感障碍的研究陷入停滞。数据收集的高成本-很少有研究扫描超过一百个
患者-导致了动力不足的研究,其结果往往无法复制,无法充分建模
混淆,并且通常缺乏能力来识别调节疾病进展或恢复的因素。我们的ENIGMA
双极倡议提供了一种新的、具有成本效益的、创新的全球方法--一种新的力量来源,
通过合并资源,资本基础设施和领先的BD中心的人才,包括来自
全球48个国家ENIGMA全球双极成像基因组学联盟
无序-建立在我们蓬勃发展的谜财团。ENIGMA的方法融合了数万个
对个体的研究“给予了我们前所未有的力量”,并且正在“打破神经科学的僵局”(纽约
Times)。《柳叶刀》将ENIGMA誉为“众包与神经科学的结合”。在设计ENIGMA-Bipolar
在这一倡议下,我们确定了ENIGMA双极工作组中最富有成效的活动,并组织了这些活动
分为3个主题-成像,基因组学和交叉疾病比较。这一全球倡议解决了关键问题,
BD中的问题:疾病如何影响大脑?哪些影像学和基因组生物标志物有助于诊断,
监测治疗并预测结果BD遗传易感性位点如何影响大脑?与全球
数据和来自15个国家的专家团队(见支持信),我们处理成像,基因组,和预测
关于BD的问题具有前所未有的力量。巴西、日本、美国、加拿大、挪威、
荷兰、德国、法国、澳大利亚和南非--我们可以重现哪些大脑差异
检测BD(结构/扩散MRI,连接组学和静息状态fMRI)?它们在生命中是如何变化的,
与疾病持续时间,按人口统计学,女性与男性,按发病年龄,亚型和治疗?使用
ENIGMA的协调协议,我们将分析BD中最大的多站点神经成像数据集-
不同的年龄、种族、治疗反应--以跟踪全球疾病。在一个新的跨障碍伙伴关系中
在ENIGMA-BD和MDD中,我们使用ENIGMA的数据驱动模型来检测成像和基因组生物标志物,
区分这两种疾病并确定亚型。在协调了各种疾病的数据元素后,我们将
创建影响BD预后的可操作因素的排名列表。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ole A Andreassen其他文献
Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation
按时间表达模式对精神分裂症基因进行聚类有助于功能解释
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:6.6
- 作者:
D. van der Meer;W. Cheng;J. Rokicki;Sara Fernandez;Alexey Shadrin;O. Smeland;Friederike Ehrhart;Sinan Gülöksüz;L. Pries;Bochao Lin;Bart P F Rutten;J. van os;M. O’Donovan;A. Richards;N. Steen;S. Djurovic;L. Westlye;Ole A Andreassen;T. Kaufmann - 通讯作者:
T. Kaufmann
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.
全基因组分析揭示了 MAPT、MOBP 和 APOE 位点在散发性额颞叶痴呆中的潜在作用。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:9.8
- 作者:
Claudia Manzoni;D. Kia;Raffaele Ferrari;G. Leonenko;Beatrice Costa;Valentina Saba;Edwin Jabbari;M. Tan;D. Albani;V. Álvarez;Ignacio Alvarez;Ole A Andreassen;Antonella Angiolillo;A. Arighi;Matt Baker;L. Benussi;V. Bessi;G. Binetti;Daniel J. Blackburn;Mercè Boada;B. Boeve;S. Borrego;B. Borroni;G. Bråthen;W. Brooks;A. C. Bruni;P. Caroppo;S. Bandres;J. Clarimón;R. Colao;C. Cruchaga;Adrian Danek;Sterre C. M. de Boer;I. de Rojas;A. Di Costanzo;Dennis W. Dickson;J. Diehl‐Schmid;Carol Dobson;O. Dols;Aldo Donizetti;E. Dopper;Elisabetta Durante;C. Ferrari;G. Forloni;F. Frangipane;Laura Fratiglioni;M. Kramberger;Daniela Galimberti;Maurizio Gallucci;P. García;R. Ghidoni;G. Giaccone;Caroline Graff;N. Graff;Jordan Grafman;Glenda M Halliday;Dena G. Hernandez;L. Hjermind;John R. Hodges;G. Holloway;E. Huey;I. Illán;K. Josephs;D. Knopman;M. Kristiansen;John B. Kwok;I. Leber;H. Leonard;Ilenia Libri;A. Lleó;Ian R. A. Mackenzie;G. Madhan;R. Maletta;M. Marquié;A. Maver;M. Menéndez;Graziella Milan;Bruce L. Miller;Christopher M. Morris;Huw R. Morris;B. Nacmias;J. Newton;Jørgen E. Nielsen;Christer Nilsson;V. Novelli;Alessandro Padovani;S. Pal;F. Pasquier;P. Pástor;Robert Perneczky;B. Peterlin;R. C. Petersen;Olivier Piguet;Y. Pijnenburg;A. Puca;R. Rademakers;I. Rainero;L. Reus;A. Richardson;Matthias Riemenschneider;E. Rogaeva;Boris Rogelj;S. Rollinson;H. Rosen;G. Rossi;James B. Rowe;E. Rubino;Agustin Ruiz;Erika Salvi;R. Sánchez;S. Sando;A. Santillo;Jennifer A. Saxon;Johannes CM. Schlachetzki;S. Scholz;H. Seelaar;W. Seeley;M. Serpente;S. Sorbi;S. Sordon;Peter St. George;Jennifer C. Thompson;C. van Broeckhoven;V. V. Van Deerlin;S. J. van der Lee;J. V. van Swieten;Fabrizio Tagliavini;J. van der Zee;Arianna Veronesi;Emilia Vitale;M. L. Waldo;Jennifer S. Yokoyama;Mike A Nalls;P. Momeni;Andy Singleton;John Hardy;Valentina Escott - 通讯作者:
Valentina Escott
Improved functional mapping with GSA-MiXeR implicates biologically specific gene-sets and estimates enrichment magnitude
使用 GSA-MiXeR 改进功能图谱,揭示生物特异性基因集并估计富集程度
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
O. Frei;G. Hindley;A. Shadrin;D. Meer;B. Akdeniz;W. Cheng;K. S. O'Connell;S. Bahrami;N. Parker;O. Smeland;Dominic;Holland;C. D. Leeuw;D. Posthuma;Ole A Andreassen;A. M. Dale - 通讯作者:
A. M. Dale
F49. EPIGENETIC MODULATION OF THE EFFECT OF WINTER BIRTHS IN SCHIZOPHRENIA AND BIPOLAR DISORDER
F49. 精神分裂症和双相情感障碍中冬季出生影响的表观遗传调节
- DOI:
10.1016/j.euroneuro.2023.08.437 - 发表时间:
2023-10-01 - 期刊:
- 影响因子:6.700
- 作者:
Ustat Bedi;Anne-Kristin Stavrum;Ingrid Melle;Ole A Andreassen;Stephanie Le Hellard - 通讯作者:
Stephanie Le Hellard
W21. GENETIC OVERLAP OF SEVERE PSYCHIATRIC DISORDERS WITH LUNG FUNCTION AND ASTHMA SUGGESTS SHARED BIOLOGICAL MECHANISMS
严重精神障碍与肺功能和哮喘的遗传重叠表明存在共同的生物学机制
- DOI:
10.1016/j.euroneuro.2024.08.230 - 发表时间:
2024-10-01 - 期刊:
- 影响因子:6.700
- 作者:
Zheng-An Lu;Alexander Ploner;Piotr Jaholkowski;Alexy Shadrin;Bronwyn Haasdyk;Ole A Andreassen;Sarah Bergen - 通讯作者:
Sarah Bergen
Ole A Andreassen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ole A Andreassen', 18)}}的其他基金
3/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact
3/7 精神病学基因组学联盟:推进发现和影响
- 批准号:
10380568 - 财政年份:2021
- 资助金额:
$ 58.95万 - 项目类别:
3/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact
3/7 精神病学基因组学联盟:推进发现和影响
- 批准号:
10611848 - 财政年份:2021
- 资助金额:
$ 58.95万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Determining the mechanism of action of cis-acting modifiers on the age of onset of Huntington Disease
确定顺式作用修饰剂对亨廷顿病发病年龄的作用机制
- 批准号:
417256 - 财政年份:2019
- 资助金额:
$ 58.95万 - 项目类别:
Studentship Programs
Effect of age of onset of contraception use on brain functioning.
避孕开始年龄对大脑功能的影响。
- 批准号:
511267-2017 - 财政年份:2017
- 资助金额:
$ 58.95万 - 项目类别:
University Undergraduate Student Research Awards
Non-random occurrence and early age of onset of diverse lymphoid cancers in families supports the existence of genetic risk factors for multiple lymphoid cancers.
家族中多种淋巴癌的非随机发生和发病年龄较早,支持多种淋巴癌存在遗传危险因素。
- 批准号:
347105 - 财政年份:2016
- 资助金额:
$ 58.95万 - 项目类别:
Polish-German Child Bilingualism: The Role of Age of Onset for Long-Term Achievement
波兰-德国儿童双语:发病年龄对长期成就的作用
- 批准号:
277135691 - 财政年份:2015
- 资助金额:
$ 58.95万 - 项目类别:
Research Grants
Bioinformatics strategies to relate age of onset with gene-gene interaction
将发病年龄与基因间相互作用联系起来的生物信息学策略
- 批准号:
9097781 - 财政年份:2015
- 资助金额:
$ 58.95万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
9212684 - 财政年份:2014
- 资助金额:
$ 58.95万 - 项目类别:
Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration
早期 AD 发病年龄:临床异质性和网络退化
- 批准号:
8696557 - 财政年份:2014
- 资助金额:
$ 58.95万 - 项目类别:
Effects of delaying age of onset of binge drinking on adolescent brain development: A proposal to add neuroimaing measures to the CO-Venture Trial.
延迟酗酒的发病年龄对青少年大脑发育的影响:在 CO-Venture 试验中添加神经影像测量的建议。
- 批准号:
267251 - 财政年份:2012
- 资助金额:
$ 58.95万 - 项目类别:
Operating Grants
Stress Effects on Alcohol Consumption: Age of onset and genes in heavy drinkers
压力对饮酒的影响:酗酒者的发病年龄和基因
- 批准号:
8606722 - 财政年份:2012
- 资助金额:
$ 58.95万 - 项目类别:
Marijuana: Neurobiologic Correlates of Age of Onset
大麻:发病年龄的神经生物学相关性
- 批准号:
8644793 - 财政年份:2012
- 资助金额:
$ 58.95万 - 项目类别:














{{item.name}}会员




